Rational engineering of antibody therapeutics targeting multiple oncogene pathways.

Rational engineering of antibody therapeutics targeting multiple oncogene pathways.

Item
http://www.wikidata.org/entity/Q42854245
Strengthening relationships: amyloids create adhesion nanodomains in yeasts.Rapid optimization and prototyping for therapeutic antibody-like molecules.7th annual European Antibody Congress 2011: November 29-December 1, 2011, Geneva, Switzerland.IBC's 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society, December 5-8, 2011, San Diego, CA.Cross-arm binding efficiency of an EGFR x c-Met bispecific antibody.Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodies.Using network biology to bridge pharmacokinetics and pharmacodynamics in oncology.Enhanced tumor-targeting selectivity by modulating bispecific antibody binding affinity and format valence.Selective Targeting of Cells via Bispecific Molecules That Exploit Coexpression of Two Intracellular Proteins.Aggregates, crystals, gels, and amyloids: intracellular and extracellular phenotypes at the crossroads of immunoglobulin physicochemical property and cell physiology.Efficient production of single-chain fragment variable-based N-terminal trimerbodies in Pichia pastoris.Recombinant Antibodies to Arm Cytotoxic Lymphocytes in Cancer Immunotherapy.
P2860

Rational engineering of antibody therapeutics targeting multiple oncogene pathways.

Item
http://www.wikidata.org/entity/Q42854245
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Rational engineering of antibody therapeutics targeting multiple oncogene pathways.
@en
Rational engineering of antibody therapeutics targeting multiple oncogene pathways.
@nl
type
label
Rational engineering of antibody therapeutics targeting multiple oncogene pathways.
@en
Rational engineering of antibody therapeutics targeting multiple oncogene pathways.
@nl
prefLabel
Rational engineering of antibody therapeutics targeting multiple oncogene pathways.
@en
Rational engineering of antibody therapeutics targeting multiple oncogene pathways.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Rational engineering of antibody therapeutics targeting multiple oncogene pathways.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932